Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/1993
05/11/1993US5210076 Methods of treating Parkinson's disease using melanin
05/10/1993CA2082446A1 Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections
05/05/1993EP0540209A1 Imidazole derivatives and pharmaceutical compositions containing the same
05/05/1993EP0539527A1 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors
05/04/1993US5208256 Treatment of ocular hypertension with a synergistic combination for ocular administration
05/04/1993CA1317230C Aqueous preparation of 9-methyl-3-(1h-tetrazol-5-yl)- 4h-pyrido ¬1,2-a|pyrimidin-4-one potassium salt
04/1993
04/30/1993WO1993009087A1 Ethynyl alanine amino diol compounds for treatment of hypertension
04/30/1993CA2115847A1 Ethynyl alanine amino diol compounds for treatment of hypertension
04/29/1993WO1993008193A1 Imidazole derivatives and pharmaceutical compositions containing the same
04/29/1993WO1993007840A1 Enzyme-orthokeratology
04/29/1993CA2118802A1 Imidazole derivatives and pharmaceutical compositions containing the same
04/28/1993EP0539330A1 Process for the preparation of substituted indoles
04/28/1993EP0539329A1 Acetenyl compounds useful as leukotrien antagonists
04/28/1993EP0538399A1 Cyclic cell adhesion modulation compounds
04/28/1993EP0538384A1 Oxamides
04/27/1993US5206241 Labdanes and process for their preparation
04/27/1993US5206237 Benzodiazepine analogs
04/27/1993US5206234 Benzolactam analogs as antagonists of cck
04/27/1993US5206008 Using androstene(diol or triol)
04/27/1993CA1316932C Methods and compositions for inhibiting lipoxygenase
04/26/1993CA2081303A1 Process for the preparation of substituted indoles
04/26/1993CA2081262A1 Acetylene compounds
04/21/1993EP0538000A1 Indole and indazole carbamates as leukotriene antagonists
04/21/1993EP0537937A2 Substituted pyrazino 2,3-D pyrimidinones as angiotensin II antagonists
04/21/1993EP0537318A1 New non-hygroscopic mono-ammonium salts.
04/20/1993US5204331 Composition for debridement of retained lens materials
04/20/1993CA1316458C Pharmaceutical composition for piperidinoalkanol derivatives
04/18/1993CA2080405A1 Indole carbamates as leukotriene antagonists
04/16/1993CA2080403A1 Tricyclic thienothiopyrans
04/15/1993WO1993007109A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same
04/15/1993WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
04/15/1993WO1993006856A1 Treating ophthalmic fibrosis using interferon-alpha
04/15/1993WO1993006827A1 Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
04/15/1993WO1993006818A1 Dermatological and/or cosmetological composition containing retinoids
04/15/1993CA2120950A1 Treating ophthalmic fibrosis using interferon-alpha
04/15/1993CA2120606A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phthalazineacetic acids and derivatives, preparations thereof and drugs containing same
04/15/1993CA2120603A1 Topical opthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
04/14/1993EP0536817A1 Azabicyclic compounds as tachykinin antagonists
04/14/1993EP0536262A1 Substituted histidines
04/14/1993EP0446268B1 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma
04/13/1993US5202328 Substituted fused pyrimidinones
04/08/1993CA2079982A1 Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists
04/08/1993CA2079770A1 Angiotensin ii antagonists incorporating a substituted 1, 3-benzodioxole and 1, 3-benzodithiole
04/07/1993EP0535926A1 (Hetero-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
04/07/1993EP0535545A1 Artificial tears containing oil and wax
04/07/1993EP0535521A2 Condensed oxazole and thiazole derivatives as leukotriene biosynthesis inhibitors
04/07/1993EP0535200A1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
04/07/1993CN1070645A Imidazolyl-alkenoic acids
04/06/1993US5200550 Administering for dermatologic, rheumatismal, respiratory or ophthalomologic disorders
04/06/1993CA1315685C Pharmaceutical compositions based on benzoic benzopyranyl and benzothiopyranyl compounds
04/06/1993CA1315678C Alpha-tocopherol based vesicles
04/03/1993CA2079658A1 Dry eye treatment process and solution
04/01/1993WO1993006105A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
04/01/1993WO1993005779A1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
03/1993
03/31/1993EP0534706A1 Quinazolinones and pyridopyrimidinones useful as angiotensin II antagonists
03/31/1993EP0533703A1 Steroids which inhibit angiogenesis
03/30/1993US5198567 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
03/30/1993US5198438 Angiotensin ii antagonists incorporating a substituted thiophene or furan
03/30/1993CA1315201C Pharmaceutical compounds based on benzamido aromatic compounds
03/26/1993CA2079079A1 Quinazolinones and pyridopyrimidinones
03/25/1993CA2078810A1 Leukotriene biosynthesis inhibitors
03/24/1993EP0533516A2 Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them
03/24/1993EP0532900A1 The use of nimesulide in the treatment of cataract
03/24/1993EP0532862A1 Use of rapamycin for the preparation of a medicament for the treatment of ocular inflammation
03/23/1993US5196449 Vision defects
03/23/1993CA1314891C Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid like activity
03/18/1993WO1993005031A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
03/17/1993EP0532456A1 1-Acylpiperidine derivatives and their use as substance P antagonists
03/17/1993EP0532410A1 N-substituted heterocyclic derivatives as angiotensin II inhibitors
03/17/1993EP0531529A1 Process for preparing aqueous suspension
03/17/1993EP0516685A4 Artificial tears
03/17/1993CN1020098C Production for thiolactam-N-acetic acid derivatives
03/17/1993CN1020095C Process for dichloroaniline derivatives
03/16/1993US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs
03/11/1993CA2077967A1 N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
03/10/1993EP0531219A1 Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs
03/10/1993EP0531078A1 (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form
03/10/1993EP0530198A1 Heterocyclic compounds as aldose reductase inhibitors
03/10/1993EP0439570B1 A novel use of beta-receptor blocking agents for treatment of menieres' disease
03/09/1993US5192746 Cyclic cell adhesion modulation compounds
03/09/1993CA1314220C Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
03/06/1993CA2076722A1 Pharmaceutical agents
03/04/1993WO1993004056A1 New leukotriene-b4 antagonists, methods of preparing them and their use as drugs
03/04/1993WO1993003731A1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
03/04/1993WO1993003726A1 Muscarinic agonists
03/04/1993WO1993003722A1 Imidazolyl-alkenoic acids
03/04/1993WO1993003718A1 Pharmaceutical composition containing carbachol and other cholinergic substances
03/04/1993CA2114951A1 New leukotriene-b antagonists, methods of preparing them and their use as drugs
03/03/1993EP0530060A1 Medication based on neutralised sulphur derivatives
03/03/1993EP0529749A1 Leukotriene-B4-antagonists, method for their preparation, and their use as medicaments
03/03/1993EP0529253A1 Phenylalkylderivatives, compounds containing them and process for their fabrication
03/03/1993EP0528875A1 Enzymatic disinsertion of vitreous body
03/03/1993EP0528861A1 Composition and treatment with biologically active peptides and toxic cations
03/02/1993US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions
03/02/1993US5190948 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes
02/1993
02/24/1993EP0528776A1 Pharmaceutical composition containing carbachol and other cholinergic substances
02/24/1993EP0528762A1 N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists
02/24/1993EP0527801A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors
02/23/1993US5189050 Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder
02/21/1993CA2076443A1 1-(alcoxybenzyl)piperazins amidic compounds, process for their preparation and pharmaceutical compositions containing same